COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01CAH
|
|||
Drug Name |
Mesenchymal stem cells
|
|||
Synonyms |
MSCs
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 2 | [1] | |
Other Indication | Epidermolysis bullosa | Approved | [2] | |
Therapeutic Class |
Antiviral Agents
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04288102) Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19). U.S. National Institutes of Health. | |||
2 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (FDA ORPHAN DRUG) 427014 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.